Results
|
|
1161.
|
Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib. [electronic resource] by
- Prat, Aleix
- Cheang, Maggie C U
- Galván, Patricia
- Nuciforo, Paolo
- Paré, Laia
- Adamo, Barbara
- Muñoz, Montserrat
- Viladot, Margarida
- Press, Michael F
- Gagnon, Robert
- Ellis, Catherine
- Johnston, Stephen
Producer: 20170221
In:
JAMA oncology vol. 2
Availability: No items available.
|
|
|
1162.
|
|
|
|
1163.
|
Targeting the EphB4 receptor tyrosine kinase sensitizes HER2-positive breast cancer cells to Lapatinib. [electronic resource] by
- Ding, Jinlei
- Yao, Yating
- Huang, Gena
- Wang, Xiaonan
- Yi, Jingyan
- Zhang, Nan
- Liu, Chongya
- Wang, Kainan
- Zhang, Yuan
- Wang, Min
- Liu, Pixu
- Ye, Mingliang
- Li, Man
- Cheng, Hailing
Producer: 20201215
In:
Cancer letters vol. 475
Availability: No items available.
|
|
|
1164.
|
|
|
|
1165.
|
|
|
|
1166.
|
|
|
|
1167.
|
|
|
|
1168.
|
Bioequivalence study with lapatinib powder for oral suspension and the original tablet formulation in cancer patients. [electronic resource] by
- Koch, Kevin M
- Ferron-Brady, Geraldine
- Lemmon, Colleen
- Cartee, Leanne
- Hollyfield, Hedy
- D'Amelio, Anthony M
- Piepszak, Alexandra
- Swaby, Ramona F
- Curran, David
- Arya, Niki
Producer: 20180116
In:
Clinical pharmacology in drug development vol. 4
Availability: No items available.
|
|
|
1169.
|
|
|
|
1170.
|
|
|
|
1171.
|
|
|
|
1172.
|
Preclinical evaluation of a novel triple-acting PIM/PI3K/mTOR inhibitor, IBL-302, in breast cancer. [electronic resource] by
- Kennedy, Sean P
- O'Neill, Michael
- Cunningham, Darren
- Morris, Patrick G
- Toomey, Sinead
- Blanco-Aparicio, Carmen
- Martinez, Sonia
- Pastor, Joaquin
- Eustace, Alex J
- Hennessy, Bryan T
Producer: 20201120
In:
Oncogene vol. 39
Availability: No items available.
|
|
|
1173.
|
|
|
|
1174.
|
|
|
|
1175.
|
Activated phosphoinositide 3-kinase/AKT signaling confers resistance to trastuzumab but not lapatinib. [electronic resource] by
- O'Brien, Neil A
- Browne, Brigid C
- Chow, Lucy
- Wang, Yuhua
- Ginther, Charles
- Arboleda, Jane
- Duffy, Michael J
- Crown, John
- O'Donovan, Norma
- Slamon, Dennis J
Producer: 20100916
In:
Molecular cancer therapeutics vol. 9
Availability: No items available.
|
|
|
1176.
|
|
|
|
1177.
|
Lapatinib, a dual EGFR and HER2 tyrosine kinase inhibitor, downregulates thymidylate synthase by inhibiting the nuclear translocation of EGFR and HER2. [electronic resource] by
- Kim, Hwang-Phill
- Yoon, Young-Kwang
- Kim, Jin-Won
- Han, Sae-Won
- Hur, Hyung-Seok
- Park, Jinah
- Lee, Ju-Hee
- Oh, Do-Youn
- Im, Seock-Ah
- Bang, Yung-Jue
- Kim, Tae-You
Producer: 20091117
In:
PloS one vol. 4
Availability: No items available.
|
|
|
1178.
|
Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck. [electronic resource] by
- Del Campo, J M
- Hitt, R
- Sebastian, P
- Carracedo, C
- Lokanatha, D
- Bourhis, J
- Temam, S
- Cupissol, D
- De Raucourt, D
- Maroudias, N
- Nutting, C M
- Compton, N
- Midwinter, D
- Downie, L
- Biswas-Baldwin, N
- El-Hariry, I
- Harrington, K J
Producer: 20111101
In:
British journal of cancer vol. 105
Availability: No items available.
|
|
|
1179.
|
|
|
|
1180.
|
Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA. [electronic resource] by
- Paroni, G
- Fratelli, M
- Gardini, G
- Bassano, C
- Flora, M
- Zanetti, A
- Guarnaccia, V
- Ubezio, P
- Centritto, F
- Terao, M
- Garattini, E
Producer: 20120925
In:
Oncogene vol. 31
Availability: No items available.
|